MolDX proposes Medicare coverage for genome-wide hematologic testing
Go back to MolDX proposes Medicare coverage for genome-wide hematologic testing| (NASDAQ: BNGO) | Delayed: 1.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $ | |||
| Open | $1.83 | 52 Week Low | $ | |||
| Day High | $1.83 | P/E | N/A | |||
| Day Low | $1.83 | EPS | $ | |||
| Volume | 4,429 | |||||
